Insider Trading Activity NeoGenomics, Inc. (NASDAQ:NEO) – Director Bought 20,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For NeoGenomics, Inc. (NASDAQ:NEO)

Alison L Hannah , Director of NeoGenomics, Inc. (NASDAQ:NEO) reportedly Bought 20,000 shares of the company’s stock at an average price of 9.19 for a total transaction amount of $183,800.00 SEC Form

Insider Trading History For NeoGenomics, Inc. (NASDAQ:NEO)

  • On 4/30/2013 Steven C Jones, Director, sold 100,000 with an average share price of $3.71 per share and the total transaction amounting to $371,000.00.View SEC Filing
  • On 11/25/2013 Steven C Jones, VP, sold 112,969 with an average share price of $3.58 per share and the total transaction amounting to $404,429.02.View SEC Filing
  • On 12/3/2013 Robert P Gasparini, Insider, sold 32,146 with an average share price of $3.67 per share and the total transaction amounting to $117,975.82.View SEC Filing
  • On 12/5/2013 Robert P Gasparini, Insider, sold 32,996 with an average share price of $3.67 per share and the total transaction amounting to $121,095.32.View SEC Filing
  • On 12/9/2013 George Cardoza, CFO, sold 20,000 with an average share price of $3.66 per share and the total transaction amounting to $73,200.00.View SEC Filing
  • On 12/11/2013 Robert P Gasparini, Insider, sold 20,100 with an average share price of $3.70 per share and the total transaction amounting to $74,370.00.View SEC Filing
  • On 3/5/2014 Michael T Dent, Director, sold 300,000 with an average share price of $3.00 per share and the total transaction amounting to $900,000.00.View SEC Filing

    • Analyst Ratings For NeoGenomics, Inc. (NASDAQ:NEO)
    These are 1 Sell Rating, 4 Buy Ratings .
    The current consensus rating for NeoGenomics, Inc. (NASDAQ:NEO) is Buy (Score: 2.60) with a consensus target price of $10.75 , a potential (13.76% upside)

    Analyst Ratings History For NeoGenomics, Inc. (NASDAQ:NEO)

    • On 10/26/2015 William Blair Reiterated Rating Buy
    • On 1/7/2016 Janney Montgomery Scott Initiated Coverage of rating Buy with a price target of $11.00
    • On 5/11/2016 Roth Capital Initiated Coverage of rating Buy with a price target of $10.00
    • On 7/9/2016 Craig Hallum Reiterated Rating Buy
    • On 7/27/2016 Benchmark Co. Boost Price Target of rating Buy with a price target of $10.00 to $12.00
    • On 9/8/2016 Raymond James Financial, Inc. Initiated Coverage of rating Outperform with a price target of $10.00
    • On 10/3/2016 First Analysis Initiated Coverage of rating Overweight with a price target of $11.00

    Recent Trading Activity for NeoGenomics, Inc. (NASDAQ:NEO)
    Shares of NeoGenomics, Inc. closed the previous trading session at 9.45 up +0.05 0.53% with 443,571 shares trading hands.